3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Migraine with Aura: new trials by email Literature Review of Migraine with Aura trials Research Report on Migraine with Aura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Dihydroergotamine - Migraine, Migraine With Aura | Phase 1 | Completed | Satsuma Pharmaceuticals, Inc. | 36 | 2021-03-05 | 2022-04-20 |
| A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Dihydroergotamine - Migraine With Aura, Migraine Without Aura | Phase 1 | Completed | Satsuma Pharmaceuticals, Inc. | 46 | 2018-09-11 | 2019-11-26 |
| Botox Injection in Treatment of Chronic Migraine Botulinum Toxin Type A - Migraine Disorders | Phase 1 / Phase 2 | Completed | Norwegian University of Science and Technology | 10 | 2015-02-01 | 2016-05-23 |
Migraine Disorders (3) · Migraine without Aura (3) · Headache Disorders (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Headache Disorders, Primary (3) · Nervous System Diseases (3) · Headache Disorders (2)
Dihydroergotamine (2) · Botulinum Toxins, Type A (1)
Satsuma Pharmaceuticals, Inc. (2) · Norwegian University of Science and Technology (1)
United States (2) · Norway (1)
Erling A Tronvik, PhD, MD (1) · Jeffrey A Levy, MD, PhD (1) · Jeffrey Levy, MD (1)
PMID 27154997, PMID 31985049, PMID 38413540
2014 (1)